• Yemisi Alli Smith Ekiti State University
  • Bukola Aluko Biochemistry Department, Ekiti State University, Nigeria
  • Olajumoke Ojo Biochemistry Department, Ekiti State University, Nigeria
  • Samuel Fayomi Biochemistry Department, Ekiti State University, Nigeria


Objective: Hyperlipidemia has been described as one of the greatest risk factors contributing to prevalence and severity of cardiovascular diseases which has been identified as a primary cause of death. This study evaluates the lipid-lowering effects of aqueous extract of Emilia praetermissa (EP) leaves.

Methods: The investigation was carried out on rats induced with Carbon tetrachloride (CCl4 1ml/kg body weight), pretreated with the aqueous extracts of Emilia praetermissa and then compared with a standard hypolipidemic drug, Simvastatin. The effects of Emilia praetermissa on the lipid profile was assessed by measuring the levels of total cholesterol, triglyceride, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol. The effect on HMGCoA Reductase and Lecithine Cholesterol Acyltransferase (LCAT) which are important enzymes in lipid metabolism were also evaluated in the plasma, liver and heart of albino rats.

Results: Administration of 50, 100 and 200 mg/kg doses of aqueous extract of Emilia praetermissa leaves led to a significant reduction (P <0.05) in total cholesterol, LDL cholesterol, triglyceride levels and a significant increase (P <0.05) in HDL cholesterol in the tissues in a manner close to that of Normal and Standard control group.  Emilia praetermissa  aqueous extract  led to a significant increase (P <0.05) in the activity of LCAT and inhibition of HMGCoA reductase. 

Conclusion: These results suggest that Emilia praetermissa leaves could play a cardio protective role and probably serve as a new potential natural product for the management of hyperlipidema.  Further investigations are warranted to elucidate the mechanism of its lipid-lowering action.

Keywords: Hyperlipidemia, Emilia praetermissa, Lipid Profile, HMG- CoA reductase, LCAT.


Download data is not yet available.


1. Levy D and Brink S. In A Change of Heart: How the people of Framingham, Massachusetts, helped unravel the mysteries of cardiovascular disease, Edited by Alfred A. Knopf, (New York), 268, (2005).
2. Ginghina C, Bejan I,Ceck C. D. Modern risk stratification in coronary heart disease.J. Med. Life, 4(4): 377-386, (2011).
3. Jorgensen T, Capewell S, Prescott E, Allender S, Sans S, Zdrojewski T. Population-level changes to promote cardiovascular health. Eur. J. Prev. Cardiol, 20(3):409-21, (2013)
4. Durrington P.Dyslipidemia. Lancet 362, 717-731, (2003)
5. Nwagha U.I, Ikekpeazu E.J, Ejezie F.E, Neboh E.E, Maduka I.C. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. African Health Sciences 10:248 – 252,(2010).
6. Reddy P. V, Ahmed F. and Urooj A. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase in liver microsomes by Moringa oleifera. Polyphenols Intl. J. Pharm. Sci. Res., 3(7):2510-2516,(2012).
7. Baumann G. Photographic Guide to Wildflowers of Malawi. Wildlife and Environmental Society of Malawi Pages 166 – 167,(2005).
8. Farooq T. Phytochemical and Pharmacological Investigation of the Leaves of Carica papaya Linn (Doctoral dissertation, East West University). (2013).
9. Entaz B, Maknoon S S, Bashutosh N, Hyonok Y. Evaluation of In vitro Antioxidant and In vivo Antihyperlipidemic Activities of Methanol Extract of Aerial Part of Crassocephalum crepidioides (Asteraceae). Trop J Pharm Res; 15(3): 48-52, (2016).
10. Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg, 44: 241-251, (2010)
11. Zhang L, Wang YD, Chen WD, Wang X, Lou G, Liu N. Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice. Hepatology; 56:2336–43, (2012).
12. Ademuyiwa O, Ugbaja RN, Idumebor F, Adebawo O. Plasma Lipid Profiles and Risk of Cardiovascular Disease in Occupational Lead Exposure in Abeokuta, Nigeria. Lipids in Health and Disease: 4: 19-22, (2005)
13. Martirosyan DM, Miroshnichenko LA, Kulokawa SN, Pogojeva AV, Zoloedov VI. Amaranth Oil Application for Heart Disease and Hypertension. Lipids in Health and Disease 6: 1-5, (2007)
14. Rang, HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed. Elsevier: India. ISBN: 81-8147-917-3. (2005)
15. Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. Separate Effects of Reduced Carbohydrate Intake and Weight Loss on Atherogenic Dyslipidaemia. American Journal of Clinical Nutrition 83:1025–1031.(2006).
16. Assmann G, Gotto AM Jr. HDL Cholesterol and Protective Factors in Atherosclerosis. Circulation 109: 111-118, (2004)
17. Hadi HAR, Carr SC, Al SJ. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag; 1(3):183–98, (2005)
18. Ama M. Nya B., Nono N., Moukette M.,Zacharie S., Cyril K., Baruch A., Ngo M., Anatole P. and Jeanne N. Hypolipidemic effect and activation of Lecithin Cholesterol Acyl Transferase (LCAT) by aqueous extract of Spirulina platensis during toxicological investigation; BMC Nutrition 3(25): 3-7, (2017).
39 Views | Downloads
How to Cite
Alli Smith, Y., B. Aluko, O. Ojo, and S. Fayomi. “PROPHYLACTIC LIPID LOWERING EFFECTS OF AQUEOUS EXTRACT OF EMILIA PREATEMISSA ON CARBON TETRACHLORIDE (CCL4)-INDUCED HYPERLIPIDEMIC ALBINO RATS”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 13, no. 6, Apr. 2021, doi:10.22159/ijpps.2021v13i6.40500.
Original Article(s)